Elutia (ELUT) Revenue Growth (1y) (2020 - 2026)
Elutia (ELUT) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 7.30% |
| 10 | Elutia | 40.25 Mn | 20.35 Mn | 1.45 Mn | -11.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52% |
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | -9.26% |
| Jun 30, 2025 | -0.45% |
| Mar 31, 2025 | -55.92% |
| Dec 31, 2024 | -52.07% |
| Sep 30, 2024 | -40.23% |
| Jun 30, 2024 | -0.94% |
| Mar 31, 2024 | 4.72% |
| Dec 31, 2023 | -10.81% |
| Sep 30, 2023 | 4.75% |
| Jun 30, 2023 | -49.75% |
| Mar 31, 2023 | -44.39% |
| Dec 31, 2022 | -39.35% |
| Sep 30, 2022 | -49.07% |
| Jun 30, 2022 | 3.93% |
| Mar 31, 2022 | -10.78% |
| Dec 31, 2021 | -12.88% |
| Sep 30, 2021 | -2.45% |
| Jun 30, 2021 | 41.74% |